Srsf2(P95H) initiates myeloid bias and myelodysplastic/myeloproliferative syndrome from hemopoietic stem cells
Monique F Smeets, Shuh Ying Tan, Jane Jialu Xu, Govardhan Anande, Ashwin Unnikrishnan, Alistair M Chalk, Scott R Taylor, John E Pimanda, Meaghan Wall, Louise E Purton, Carl R Walkley
Blood | AMER SOC HEMATOLOGY | Published : 2018
Awarded by Cancer Council of Victoria
Awarded by National Health and Medical Research Council (NHMRC)
Awarded by Victorian Cancer Agency Research Fellowship
Awarded by NHMRC
This work was supported by the Leukaemia Foundation (C.R.W., Phillip Desbrow Senior Research Fellow [SRF]; M.W., grant-in-aid; S.Y.T., PhD scholarship); Cancer Council of Victoria (C.R.W., M.W., A. M.C.; APP1126010); National Health and Medical Research Council (NHMRC; J.E.P., APP1024363/APP1102589); Cancer Institute of NSW Translational Cancer Research Network (J.E.P.); South Eastern Area Laboratory Services (J.E.P.), Anthony Rothe Memorial Trust (A.U.); Victorian Cancer Agency Research Fellowship (C.R.W.; MCRF15015); NHMRC SRF (L.E.P.; APP1003339); UNSW International PhD scholarship (G.A.); and Tom Bee Stem Cell Research Fund (G.A.) and in part by the Victorian State Government OIS.